Transient increase of cytokines in the acute ischemic tissue is beneficial to cell-based therapeutic angiogenesis

Circulation Journal

Volumn 72, Issue 12, 2008, Pages 2075-2080

  Qin, Shu Lan ^a   Li, Tao Sheng ^a   Kubo, Masayuki ^a   Ohshima, Mako ^a   Furutani, Akira ^a   Hamano, Kimikazu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute ischemic tissue; Angiogenesis; Bone marrow cells; Cytokines

Indexed keywords

CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEIN; PROTEIN;

ACUTE DISEASE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; C57BL 6 MOUSE; CELL ADHESION; CELL CULTURE; CELL MIGRATION; CELL SURVIVAL; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CYTOKINE PRODUCTION; IMPLANTATION; IN VIVO STUDY; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; TRANSGENIC MOUSE;

ACUTE DISEASE; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL ADHESION; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CCL2; CHRONIC DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 2; GREEN FLUORESCENT PROTEINS; HINDLIMB; INTERLEUKIN-1BETA; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE PROTEINS; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; REGIONAL BLOOD FLOW; TIME FACTORS; UP-REGULATION;

EID: 56849112532     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0392     Document Type: Article

References (29)

1. Saito Y, Sasaki K, Katsuda Y, Murohara T, Takeshita Y, Okazaki T, et al. Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease. Circ J 2007; 98: 1187-1192.
2. Tateno K, Minamino T, Toko H, Akazawa H, Shimizu N, Takeda S, et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 2006; 98: 1194-1202.
3. + stem cells plays a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol 2003; 285: 931-937.
4. Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 2008; 28: 208-216.
5. Li TS, Hayashi M, Ito H, Furutani A, Murata T, Matsuzaki M, et al. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation 2005; 111: 2438-2445.
6. + stem cells. Am J Physiol Heart Circ Physiol 2004; 286: 1236-1241.
7. Li TS, Ito H, Hayashi M, Furutani A, Matsuzaki M, Hamano K. Cellular expression of integrin-β1 is of critical importance for inducing therapeutic angiogenesis by cell implantation. Cardiovasc Res 2005; 65: 64-72.
8. Yau TM, Kim C, Li G, Zhang Y, Weisel RD, Li RK. Maximizing ventricular function with multimodal cell-based gene therapy. Circulation 2005; 112: 1123-1128.
9. Spiegelstein D, Kim C, Zhang Y, Li G, Weisel RD, Li RK, et al. Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival. Am J Physiol Heart Circ Physiol 2007; 293: 3311-3316.
10. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 2008; 135: 799-808.
11. Hayashi M, Li TS, Ito H, Mikamo A, Hamano K. Comparison of intramyocardial and intravenous routes of delivering bone marrow cells for the treatment of ischemic heart disease: An experimental study. Cell Transplant 2004; 13: 639-647.
12. Saigawa T, Kato K, Ozawa T, Toba K, Makiyama Y, Minagawa S, et al. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 2004; 68: 1189-1193.
13. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomized controlled trial. Lancet 2002; 360: 427-435.
14. Shyu WC, Lee YJ, Liu DD, Lin SZ, Li H. Homing genes, cell therapy and stroke. Front Biosci 2006; 11: 899-907.
15. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31-47.
16. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004; 94: 1543-1553.
17. Wu Y, Ip JE, Huang J, Zhang L, Matsushita K, Liew CC, et al. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infracted myocardium. Circ Res 2006; 99: 315-322.
18. Paoni NF, Peale F, Wang F, Errett-Baroncini C, Steinmetz H, Toy K, et al. Time course of skeletal muscle repair and gene expression following acute hind limb ischemia in mice. Physiol Genomics 2002; 11: 263-272.
19. Qin SL, Li TS, Takahashi M, Hamano K. In vitro assessment of the effect of interleukin-1β on angiogenic potential of bone marrow cells. Circ J 2006; 70: 1195-1199.
20. Hartnett ME, Garcia CM, Damore PA. Release of bFGF, an endothelial cell survival factor, by osmotic shock. Invest Ophthalmol Vis Sci 1999; 40: 2954-2951.
21. Shaulian E, Resnitzky D, Shifman O, Blandino G, Amsterdam A, Yayon A, et al. Induction of Mdm2 and enhancement of cell survival by bFGF. Oncogene 1997; 15: 2717-2725.
22. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998; 17: 3261-3270.
23. Kubo M, Li TS, Suzuki R, Ohshima M, Qin SL, Hamano K. Short-term pretreatment with low-dose hydrogen peroxide enhances the efficacy of bone marrow cells for therapeutic angiogenesis. Am J Physiol Heart Circ Physiol 2007; 292: 2582-2588.
24. Hong-Geller E, Pardington PE, Cary RB, Sauer NN, Gupta G. Chemokine regulation in response to beryllium exposure in human peripheral blood mononuclear and dendritic cells. Toxicology 2006; 218: 216-218.
25. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeqer F, Honold J, et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 2005; 97: 1142-1151.
26. Fujiyama S, Amano K, Uehira K, Yoshida M, Nishiwaki Y, Nozawa Y, et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 2003; 93: 980-989.
27. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-445.
28. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301-314.
29. Kuethe F, Richartz BM, Kasper C, Sayer HG, Hoeffken K, Werner GS, et al. Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans. Int J Cardiol 2005; 100: 485-491.